🇺🇸 FDA
Patent

US 9579316

Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities

granted A61KA61K31/4709A61K31/4725

Quick answer

US patent 9579316 (Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities) held by Almirall, S.A. expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4709, A61K31/4725, A61K45/06, A61K9/0075